Application of a newly developed ELISA for BCAR1 protein for prediction of clinical benefit of tamoxifen therapy in patients with advanced breast cancer.

Files in This Item:

File	Description	Size	Format
	publisher's version	76.2 kB	Adobe PDF	Under Embargo

Title:	Application of a newly developed ELISA for BCAR1 protein for prediction of clinical benefit of tamoxifen therapy in patients with advanced breast cancer.
Author(s):	Dorssers, L.C. Grebenchtchikov, N.J. (298973405) Brinkman, A.B. (241250595) Look, M.P. Klijn, J.G.M. Geurts-Moespot, A. (298974886) Span, P.N. (14500435X) Foekens, J.A. Sweep, C.G.J. (074620967)
Publication year:	2004
Document type:	Article / Letter to editor
Journal:	Clinical chemistry
ISSN:	0009-9147
Volume:	vol. 50
Issue:	iss. 8
Start page:	p. 1445
End page:	p. 1447
Subject:	UMCN 5.2: Endocrinology and reproduction
Organization:	UMCN Extern Chemical Endocrinology Molecular Biology
Appears in Collections:	Academic bibliography

Please use this identifier to cite or link to this item: http://hdl.handle.net/2066/58218